Search Results
-
FILTER BY DATEAll Time
-
-
FILTER BY RELEVANCEMost Relevant
-
-
FILTER BY CONTENT TYPEAll Content Types
-
Strong property rightsand minimal interference will ensuretheefficiency and success of the pharmaceutical industry.
Experts criticized restrictive pharmaceutical price controls at a March 18 AEI conference.
Do we already have all the medical innovation we need?
The pharmaceutical industry is headed toward a crisis. Its successes in improving health and prolonging life have made drug therapy essential to health care. But in virtually every nation, price controls and other regulation have undermined the profit incentive, causing a massive shift in research and development from Europe...
Presidential and congressional candidates are now offering several new policy proposals that would affect the pharmaceutical industry. Most of these would attempt to control the price of pharmaceutical products or affect prices by increasing the supply of imported or reimported products. One of the principal policy issues raised by...
Successfully translating scientific discoveries requires a sense of urgency, which some disease foundations seem to have, and many big pharmas appear to need. Patients waiting expectantly for medical research to produce important new cures are finding bad news almost everywhere they turn.
Reviewing "The Myth of The Paperless Office" for the New Yorker in 2002, Malcolm Gladwell argued that if the computer had come first, and paper didn't exist, someone would have had to invent it. Paper, it turns out, is a lot more useful than we typically appreciate.
This book discusses health care reform and how pharmaceutical innovations can be developed to ensure the healthy future of America.




